loading
Precedente Chiudi:
$2.15
Aprire:
$2.15
Volume 24 ore:
86,210
Relative Volume:
0.99
Capitalizzazione di mercato:
$95.59M
Reddito:
$2.70M
Utile/perdita netta:
$5.53M
Rapporto P/E:
20.18
EPS:
0.11
Flusso di cassa netto:
$-10.55M
1 W Prestazione:
-5.13%
1M Prestazione:
-0.45%
6M Prestazione:
-7.50%
1 anno Prestazione:
+1.83%
Intervallo 1D:
Value
$2.0731
$2.25
Intervallo di 1 settimana:
Value
$2.00
$2.435
Portata 52W:
Value
$1.82
$3.09

Oramed Pharmaceuticals Inc Stock (ORMP) Company Profile

Name
Nome
Oramed Pharmaceuticals Inc
Name
Telefono
646-844-1164
Name
Indirizzo
1185 AVENUE OF THE AMERICAS, 3RD FLOOR, NEW YORK, NY
Name
Dipendente
13
Name
Cinguettio
@OramedPharma
Name
Prossima data di guadagno
2024-11-07
Name
Ultimi documenti SEC
Name
ORMP's Discussions on Twitter

Confronta ORMP con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Biotechnology icon
ORMP
Oramed Pharmaceuticals Inc
2.22 95.59M 2.70M 5.53M -10.55M 0.11
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
450.50 113.52B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
493.22 52.93B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
300.83 39.71B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
585.93 35.00B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
255.86 26.57B 3.81B -644.79M -669.77M -6.24

Oramed Pharmaceuticals Inc Stock (ORMP) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2023-01-12 Downgrade Canaccord Genuity Buy → Hold
2022-02-18 Iniziato Cantor Fitzgerald Overweight
2021-04-20 Iniziato Canaccord Genuity Buy
2021-02-09 Iniziato National Securities Buy
2020-12-03 Iniziato Alliance Global Partners Buy
2020-03-11 Iniziato Aegis Capital Buy
2019-09-11 Iniziato Ladenburg Thalmann Buy
2017-12-11 Ripresa B. Riley FBR, Inc. Buy
2016-05-26 Reiterato FBR Capital Outperform
2015-12-01 Reiterato H.C. Wainwright Buy
2015-11-19 Iniziato FBR Capital Outperform
2015-04-13 Ripresa MLV & Co Buy
2014-01-30 Reiterato Aegis Capital Buy
2014-01-08 Reiterato Aegis Capital Buy
2014-01-08 Iniziato MLV & Co Buy
2013-12-03 Iniziato Aegis Capital Buy
Mostra tutto

Oramed Pharmaceuticals Inc Borsa (ORMP) Ultime notizie

pulisher
Jun 04, 2025

Oral Biologics Market Outlook 2025: Rising Demand, Market Size, - openPR.com

Jun 04, 2025
pulisher
Jun 04, 2025

Two Sigma Investments LP Purchases 91,205 Shares of Corbus Pharmaceuticals Holdings, Inc. (NASDAQ:CRBP) - Defense World

Jun 04, 2025
pulisher
May 28, 2025

Type 2 Diabetes Pipeline 2025: Therapies Under Investigation, - openPR.com

May 28, 2025
pulisher
May 28, 2025

Oral Biologics Market in 2025-2032 Detailed Study Analysis with - openPR.com

May 28, 2025
pulisher
May 28, 2025

Acusphere (OTCMKTS:ACUS) versus Oramed Pharmaceuticals (NASDAQ:ORMP) Critical Comparison - Defense World

May 28, 2025
pulisher
May 27, 2025

Oramed Pharmaceuticals (NASDAQ:ORMP) Shares Pass Below 200-Day Moving Average – Should You Sell? - Defense World

May 27, 2025
pulisher
May 21, 2025

Oramed Pharm Extends Stock Buyback Program - TipRanks

May 21, 2025
pulisher
May 18, 2025

Dimensional Fund Advisors LP Grows Stake in Oramed Pharmaceuticals Inc. (NASDAQ:ORMP) - Defense World

May 18, 2025
pulisher
May 17, 2025

The past three years for Oramed Pharmaceuticals (NASDAQ:ORMP) investors has not been profitable - Yahoo Finance

May 17, 2025
pulisher
May 17, 2025

Oramed Pharmaceuticals (NASDAQ:ORMP) Stock Rating Lowered by StockNews.com - Defense World

May 17, 2025
pulisher
May 15, 2025

Oramed: Q1 Earnings Snapshot - New Haven Register

May 15, 2025
pulisher
May 13, 2025

Alpha Tau Medical appoints new board member By Investing.com - Investing.com India

May 13, 2025
pulisher
May 12, 2025

Alpha Tau Medical appoints new board member - Investing.com

May 12, 2025
pulisher
May 12, 2025

Alpha Tau Announces Appointment of Nadav Kidron to its Board of Directors - GlobeNewswire

May 12, 2025
pulisher
May 09, 2025

StockNews.com Downgrades Oramed Pharmaceuticals (NASDAQ:ORMP) to Sell - Defense World

May 09, 2025
pulisher
May 05, 2025

Renaissance Technologies LLC Trims Position in Oramed Pharmaceuticals Inc. (NASDAQ:ORMP) - Defense World

May 05, 2025
pulisher
May 02, 2025

LPL Financial LLC Sells 21,250 Shares of Oramed Pharmaceuticals Inc. (NASDAQ:ORMP) - Defense World

May 02, 2025
pulisher
Apr 29, 2025

Oramed Invests $36.9 Million In Alpha Tau For Strategic Growth - Finimize

Apr 29, 2025
pulisher
Apr 29, 2025

Alpha Tau Medical (DRTS) Secures $36.9M in Direct Offering with Oramed Pharmaceuticals | DRTS Stock News - GuruFocus

Apr 29, 2025
pulisher
Apr 28, 2025

Oramed invests $36.9 million in Alpha Tau cancer therapy By Investing.com - Investing.com

Apr 28, 2025
pulisher
Apr 28, 2025

Alpha Tau Closes $36.9 Mln Offering And Forms Strategic Alliance With Oramed Pharmaceuticals - Nasdaq

Apr 28, 2025
pulisher
Apr 28, 2025

Oramed Pharmaceuticals Announces $36.9 Million Investment And Strategic Collaboration With Alpha Tau Medical - marketscreener.com

Apr 28, 2025
pulisher
Apr 28, 2025

Alpha Tau Announces Closing of $36.9 Million Registered - GlobeNewswire

Apr 28, 2025
pulisher
Apr 28, 2025

Major Biotech Deal: Alpha Tau Medical Secures $36.9M Investment to Accelerate Cancer Treatment Innovation - Stock Titan

Apr 28, 2025
pulisher
Apr 28, 2025

Oramed Closes $36.9M Strategic Investment in Alpha Tau Medical - citybiz

Apr 28, 2025
pulisher
Apr 28, 2025

Oramed Completes $36.9 Million Strategic Investment in Alpha Tau Medical - marketscreener.com

Apr 28, 2025
pulisher
Apr 25, 2025

Press Release Distribution & PR Platform - ACCESS Newswire

Apr 25, 2025
pulisher
Apr 24, 2025

ORMPOramed Pharmaceuticals Inc Latest Stock News & Market Updates - Stock Titan

Apr 24, 2025
pulisher
Apr 21, 2025

What To Expect From Tesla’s (TSLA) Q1 Earnings - The Globe and Mail

Apr 21, 2025
pulisher
Apr 10, 2025

Oramed stock hits 52-week low at $1.95 amid market challenges - Investing.com Australia

Apr 10, 2025
pulisher
Apr 09, 2025

Oramed stock hits 52-week low at $1.95 amid market challenges By Investing.com - Investing.com South Africa

Apr 09, 2025
pulisher
Mar 27, 2025

Oramed Pharmaceuticals Inc. (ORMP) reports earnings - Quartz

Mar 27, 2025
pulisher
Mar 24, 2025

Oral Biologics Market Is Booming Worldwide 2025-2032 | Biocon - openPR.com

Mar 24, 2025
pulisher
Mar 21, 2025

Oramed Pharmaceuticals Inc expected to post a loss of 2 cents a shareEarnings Preview - TradingView

Mar 21, 2025
pulisher
Mar 13, 2025

Oramed Pharmaceuticals And 2 Other Penny Stocks With Promising Potential - Simply Wall St

Mar 13, 2025
pulisher
Mar 12, 2025

Oramed Pharmaceuticals Stock Plummets After Insulin Test Results - The Wall Street Journal

Mar 12, 2025
pulisher
Mar 11, 2025

Tianhui Biotech and Oramed Pharmaceuticals’ Investment in OraTech Pharmaceuticals - Global Legal Chronicle

Mar 11, 2025
pulisher
Mar 08, 2025

AllPennyStocks.com Releases a Special Report on Oramed Pharmaceuticals Inc. - ACCESS Newswire

Mar 08, 2025
pulisher
Mar 04, 2025

Oramed advances oral insulin, plans Phase 3 trial and dividend - Investing.com

Mar 04, 2025
pulisher
Mar 04, 2025

Oramed advances oral insulin, plans Phase 3 trial and dividend By Investing.com - Investing.com South Africa

Mar 04, 2025
pulisher
Mar 04, 2025

Oramed Pharmaceuticals Issues Letter to Shareholders - PR Newswire

Mar 04, 2025
pulisher
Mar 03, 2025

ORMP stock touches 52-week low at $2 amid market challenges By Investing.com - Investing.com South Africa

Mar 03, 2025
pulisher
Mar 03, 2025

ORMP stock touches 52-week low at $2 amid market challenges - Investing.com

Mar 03, 2025

Oramed Pharmaceuticals Inc Azioni (ORMP) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading
$73.62
price up icon 1.21%
$22.20
price up icon 1.79%
$20.59
price up icon 4.36%
$33.78
price up icon 0.09%
$108.49
price down icon 1.51%
biotechnology ONC
$255.86
price down icon 0.44%
Capitalizzazione:     |  Volume (24 ore):